APO Research
Talk to an analyst

APO RESEARCH · REPORT

Immune Mediated Tumor Killing Assays Service

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Immune Mediated Tumor Killing Assays Service Industry Growth and Trends Forecast to 2032

3 July 2026114 pages

Choose your research edition.

Industry ResearchImmune Mediated Tumor Killing Assays Service Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Immune Mediated Tumor Killing Assays Service Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Immune Mediated Tumor Killing Assays Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Immune Mediated Tumor Killing Assays Service Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Immune Mediated Tumor Killing Assays Service Market Analysis and Forecast 2026-2032181 pages · $4,950 USD

Market perspective

According to APO Research, the global Immune Mediated Tumor Killing Assays Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Immune Mediated Tumor Killing Assays Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Immune Mediated Tumor Killing Assays Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Immune Mediated Tumor Killing Assays Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Immune Mediated Tumor Killing Assays Service market include Agilent, Laboratories, Explicyte, Reaction Biology, Axion BioSystems, Sartorius, ICE Bioscience, Shanghai Saily Biotechnology and ProBio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Immune Mediated Tumor Killing Assays Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Immune Mediated Tumor Killing Assays Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Immune Mediated Tumor Killing Assays Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Immune Mediated Tumor Killing Assays Service.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Immune Mediated Tumor Killing Assays Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Immune Mediated Tumor Killing Assays Service Market by Company

Agilent

Laboratories

Explicyte

Reaction Biology

Axion BioSystems

Sartorius

ICE Bioscience

Shanghai Saily Biotechnology

ProBio

Charles River

Imodels

Xeno Diagnostics

Cyagen

MarinBio

Pharmalegacy

Celentyx

Crown Bioscience

Cellomatics Biosciences

Immune Mediated Tumor Killing Assays Service Segment by Type

Cytotoxic T Cell Assay

Natural Killer (NK) Cell Assay

Other

Immune Mediated Tumor Killing Assays Service Segment by Application

Cancer Research

Infectious Disease Research

Immunotherapy Development

Immune Mediated Tumor Killing Assays Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immune Mediated Tumor Killing Assays Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Immune Mediated Tumor Killing Assays Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immune Mediated Tumor Killing Assays Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Immune Mediated Tumor Killing Assays Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Immune Mediated Tumor Killing Assays Service Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Immune Mediated Tumor Killing Assays Service Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Immune Mediated Tumor Killing Assays Service Market Share by Region (2021-2026) Table 4. Global Immune Mediated Tumor Killing Assays Service Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Immune Mediated Tumor Killing Assays Service Market Share by Region (2027-2032) Table 6. Global Immune Mediated Tumor Killing Assays Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Immune Mediated Tumor Killing Assays Service Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Immune Mediated Tumor Killing Assays Service Market Size Share by Type (2021-2026) Table 9. Global Immune Mediated Tumor Killing Assays Service Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Immune Mediated Tumor Killing Assays Service Market Size Share Forecasted by Type (2027-2032) Table 11. North America Immune Mediated Tumor Killing Assays Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Immune Mediated Tumor Killing Assays Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Immune Mediated Tumor Killing Assays Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Immune Mediated Tumor Killing Assays Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Immune Mediated Tumor Killing Assays Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Immune Mediated Tumor Killing Assays Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Immune Mediated Tumor Killing Assays Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Immune Mediated Tumor Killing Assays Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Immune Mediated Tumor Killing Assays Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Immune Mediated Tumor Killing Assays Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Immune Mediated Tumor Killing Assays Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Immune Mediated Tumor Killing Assays Service Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Immune Mediated Tumor Killing Assays Service Market Size Share by Application (2021-2026) Table 24. Global Immune Mediated Tumor Killing Assays Service Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Immune Mediated Tumor Killing Assays Service Market Size Share Forecasted by Application (2027-2032) Table 26. North America Immune Mediated Tumor Killing Assays Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Immune Mediated Tumor Killing Assays Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Immune Mediated Tumor Killing Assays Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Immune Mediated Tumor Killing Assays Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Immune Mediated Tumor Killing Assays Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Immune Mediated Tumor Killing Assays Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Immune Mediated Tumor Killing Assays Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Immune Mediated Tumor Killing Assays Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Immune Mediated Tumor Killing Assays Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Immune Mediated Tumor Killing Assays Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Immune Mediated Tumor Killing Assays Service Industry Trends Table 37. Immune Mediated Tumor Killing Assays Service Industry Drivers Table 38. Immune Mediated Tumor Killing Assays Service Industry Opportunities and Challenges Table 39. Immune Mediated Tumor Killing Assays Service Industry Restraints Table 40. Global Immune Mediated Tumor Killing Assays Service Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Immune Mediated Tumor Killing Assays Service Revenue Market Share by Company (2021-2026) Table 42. Global Immune Mediated Tumor Killing Assays Service Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Immune Mediated Tumor Killing Assays Service Key Company Headquarters & Area Served Table 44. Global Immune Mediated Tumor Killing Assays Service Company, Product Type & Application Table 45. Global Immune Mediated Tumor Killing Assays Service Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Immune Mediated Tumor Killing Assays Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Agilent Company Information Table 49. Agilent Business Overview Table 50. Agilent Immune Mediated Tumor Killing Assays Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Agilent Immune Mediated Tumor Killing Assays Service Product Portfolio Table 52. Agilent Recent Development Table 53. Laboratories Company Information Table 54. Laboratories Business Overview Table 55. Laboratories Immune Mediated Tumor Killing Assays Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Laboratories Immune Mediated Tumor Killing Assays Service Product Portfolio Table 57. Laboratories Recent Development Table 58. Explicyte Company Information Table 59. Explicyte Business Overview Table 60. Explicyte Immune Mediated Tumor Killing Assays Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Explicyte Immune Mediated Tumor Killing Assays Service Product Portfolio Table 62. Explicyte Recent Development Table 63. Reaction Biology Company Information Table 64. Reaction Biology Business Overview Table 65. Reaction Biology Immune Mediated Tumor Killing Assays Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Reaction Biology Immune Mediated Tumor Killing Assays Service Product Portfolio Table 67. Reaction Biology Recent Development Table 68. Axion BioSystems Company Information Table 69. Axion BioSystems Business Overview Table 70. Axion BioSystems Immune Mediated Tumor Killing Assays Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Axion BioSystems Immune Mediated Tumor Killing Assays Service Product Portfolio Table 72. Axion BioSystems Recent Development Table 73. Sartorius Company Information Table 74. Sartorius Business Overview Table 75. Sartorius Immune Mediated Tumor Killing Assays Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Sartorius Immune Mediated Tumor Killing Assays Service Product Portfolio Table 77. Sartorius Recent Development Table 78. ICE Bioscience Company Information Table 79. ICE Bioscience Business Overview Table 80. ICE Bioscience Immune Mediated Tumor Killing Assays Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. ICE Bioscience Immune Mediated Tumor Killing Assays Service Product Portfolio Table 82. ICE Bioscience Recent Development Table 83. Shanghai Saily Biotechnology Company Information Table 84. Shanghai Saily Biotechnology Business Overview Table 85. Shanghai Saily Biotechnology Immune Mediated Tumor Killing Assays Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Shanghai Saily Biotechnology Immune Mediated Tumor Killing Assays Service Product Portfolio Table 87. Shanghai Saily Biotechnology Recent Development Table 88. ProBio Company Information Table 89. ProBio Business Overview Table 90. ProBio Immune Mediated Tumor Killing Assays Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. ProBio Immune Mediated Tumor Killing Assays Service Product Portfolio Table 92. ProBio Recent Development Table 93. Charles River Company Information Table 94. Charles River Business Overview Table 95. Charles River Immune Mediated Tumor Killing Assays Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Charles River Immune Mediated Tumor Killing Assays Service Product Portfolio Table 97. Charles River Recent Development Table 98. Imodels Company Information Table 99. Imodels Business Overview Table 100. Imodels Immune Mediated Tumor Killing Assays Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Imodels Immune Mediated Tumor Killing Assays Service Product Portfolio Table 102. Imodels Recent Development Table 103. Xeno Diagnostics Company Information Table 104. Xeno Diagnostics Business Overview Table 105. Xeno Diagnostics Immune Mediated Tumor Killing Assays Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Xeno Diagnostics Immune Mediated Tumor Killing Assays Service Product Portfolio Table 107. Xeno Diagnostics Recent Development Table 108. Cyagen Company Information Table 109. Cyagen Business Overview Table 110. Cyagen Immune Mediated Tumor Killing Assays Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Cyagen Immune Mediated Tumor Killing Assays Service Product Portfolio Table 112. Cyagen Recent Development Table 113. MarinBio Company Information Table 114. MarinBio Business Overview Table 115. MarinBio Immune Mediated Tumor Killing Assays Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. MarinBio Immune Mediated Tumor Killing Assays Service Product Portfolio Table 117. MarinBio Recent Development Table 118. Pharmalegacy Company Information Table 119. Pharmalegacy Business Overview Table 120. Pharmalegacy Immune Mediated Tumor Killing Assays Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Pharmalegacy Immune Mediated Tumor Killing Assays Service Product Portfolio Table 122. Pharmalegacy Recent Development Table 123. Celentyx Company Information Table 124. Celentyx Business Overview Table 125. Celentyx Immune Mediated Tumor Killing Assays Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Celentyx Immune Mediated Tumor Killing Assays Service Product Portfolio Table 127. Celentyx Recent Development Table 128. Crown Bioscience Company Information Table 129. Crown Bioscience Business Overview Table 130. Crown Bioscience Immune Mediated Tumor Killing Assays Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Crown Bioscience Immune Mediated Tumor Killing Assays Service Product Portfolio Table 132. Crown Bioscience Recent Development Table 133. Cellomatics Biosciences Company Information Table 134. Cellomatics Biosciences Business Overview Table 135. Cellomatics Biosciences Immune Mediated Tumor Killing Assays Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Cellomatics Biosciences Immune Mediated Tumor Killing Assays Service Product Portfolio Table 137. Cellomatics Biosciences Recent Development Table 138. North America Immune Mediated Tumor Killing Assays Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Immune Mediated Tumor Killing Assays Service Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Immune Mediated Tumor Killing Assays Service Market Share by Country (2021-2026) Table 141. North America Immune Mediated Tumor Killing Assays Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Immune Mediated Tumor Killing Assays Service Market Share Forecast by Country (2027-2032) Table 143. Europe Immune Mediated Tumor Killing Assays Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe Immune Mediated Tumor Killing Assays Service Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe Immune Mediated Tumor Killing Assays Service Market Share by Country (2021-2026) Table 146. Europe Immune Mediated Tumor Killing Assays Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe Immune Mediated Tumor Killing Assays Service Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Immune Mediated Tumor Killing Assays Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Immune Mediated Tumor Killing Assays Service Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Immune Mediated Tumor Killing Assays Service Market Share by Country (2021-2026) Table 151. Asia-Pacific Immune Mediated Tumor Killing Assays Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Immune Mediated Tumor Killing Assays Service Market Share Forecast by Country (2027-2032) Table 153. Latin America Immune Mediated Tumor Killing Assays Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Immune Mediated Tumor Killing Assays Service Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Immune Mediated Tumor Killing Assays Service Market Share by Country (2021-2026) Table 156. Latin America Immune Mediated Tumor Killing Assays Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Immune Mediated Tumor Killing Assays Service Market Share Forecast by Country (2027-2032) Table 158. Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Share by Country (2021-2026) Table 161. Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Share Forecast by Country (2027-2032) Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Immune Mediated Tumor Killing Assays Service Product Image Figure 3. Global Immune Mediated Tumor Killing Assays Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Immune Mediated Tumor Killing Assays Service Market Size (2021-2032) & (US$ Million) Figure 5. Global Immune Mediated Tumor Killing Assays Service Market Share by Region: 2025 VS 2032 Figure 6. Global Immune Mediated Tumor Killing Assays Service Market Share by Region (2021-2032) Figure 7. North America Immune Mediated Tumor Killing Assays Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Immune Mediated Tumor Killing Assays Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Immune Mediated Tumor Killing Assays Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Immune Mediated Tumor Killing Assays Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Cytotoxic T Cell Assay Image Figure 13. Global Cytotoxic T Cell Assay Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Natural Killer (NK) Cell Assay Image Figure 15. Global Natural Killer (NK) Cell Assay Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Other Image Figure 17. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Immune Mediated Tumor Killing Assays Service Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Immune Mediated Tumor Killing Assays Service Market Share by Type 2025 VS 2032 Figure 20. North America Immune Mediated Tumor Killing Assays Service Market Size Share by Type (2021-2032) Figure 21. Europe Immune Mediated Tumor Killing Assays Service Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Immune Mediated Tumor Killing Assays Service Market Size Share by Type (2021-2032) Figure 23. Latin America Immune Mediated Tumor Killing Assays Service Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Immune Mediated Tumor Killing Assays Service Market Size Share by Type (2021-2032) Figure 25. Cancer Research Image Figure 26. Global Cancer Research Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Infectious Disease Research Image Figure 28. Global Infectious Disease Research Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Immunotherapy Development Image Figure 30. Global Immunotherapy Development Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Immune Mediated Tumor Killing Assays Service Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Immune Mediated Tumor Killing Assays Service Market Share by Application 2025 VS 2032 Figure 33. North America Immune Mediated Tumor Killing Assays Service Market Size Share by Application (2021-2032) Figure 34. Europe Immune Mediated Tumor Killing Assays Service Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Immune Mediated Tumor Killing Assays Service Market Size Share by Application (2021-2032) Figure 36. Latin America Immune Mediated Tumor Killing Assays Service Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Immune Mediated Tumor Killing Assays Service Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Immune Mediated Tumor Killing Assays Service Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Immune Mediated Tumor Killing Assays Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Immune Mediated Tumor Killing Assays Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Immune Mediated Tumor Killing Assays Service Market Share by Country (2021-2032) Figure 43. Europe Immune Mediated Tumor Killing Assays Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Immune Mediated Tumor Killing Assays Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Immune Mediated Tumor Killing Assays Service Market Share by Country (2021-2032) Figure 46. Asia-Pacific Immune Mediated Tumor Killing Assays Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Immune Mediated Tumor Killing Assays Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Immune Mediated Tumor Killing Assays Service Market Share by Country (2021-2032) Figure 49. Latin America Immune Mediated Tumor Killing Assays Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Immune Mediated Tumor Killing Assays Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Immune Mediated Tumor Killing Assays Service Market Share by Country (2021-2032) Figure 52. Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Cytotoxic T Cell Assay
  • Natural Killer (NK) Cell Assay
  • Other
Applications
  • Cancer Research
  • Infectious Disease Research
  • Immunotherapy Development
Companies covered
  • Agilent
  • Laboratories
  • Explicyte
  • Reaction Biology
  • Axion BioSystems
  • Sartorius
  • ICE Bioscience
  • Shanghai Saily Biotechnology
  • ProBio
  • Charles River
  • Imodels
  • Xeno Diagnostics
  • Cyagen
  • MarinBio
  • Pharmalegacy
  • Celentyx
  • Crown Bioscience
  • Cellomatics Biosciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Immune Mediated Tumor Killing Assays Service Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Immune Mediated Tumor Killing Assays Service Market Size by Region (2021-2032)
  5. 1.4.1 Global Immune Mediated Tumor Killing Assays Service Market Size by Region (2021-2026)
  6. 1.4.2 Global Immune Mediated Tumor Killing Assays Service Market Size by Region (2027-2032)
  7. 1.5 Key Regions Immune Mediated Tumor Killing Assays Service Market Size (2021-2032)
  8. 1.5.1 North America Immune Mediated Tumor Killing Assays Service Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Immune Mediated Tumor Killing Assays Service Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Immune Mediated Tumor Killing Assays Service Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Immune Mediated Tumor Killing Assays Service Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Size Growth Rate (2021-2032)
2 Immune Mediated Tumor Killing Assays Service Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Cytotoxic T Cell Assay
  3. 2.1.2 Natural Killer (NK) Cell Assay
  4. 2.1.3 Other
  5. 2.2 Global Immune Mediated Tumor Killing Assays Service Market Size by Type
  6. 2.2.1 Global Immune Mediated Tumor Killing Assays Service Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Immune Mediated Tumor Killing Assays Service Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Immune Mediated Tumor Killing Assays Service Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Immune Mediated Tumor Killing Assays Service Market Size by Regions
  10. 2.3.1 North America Immune Mediated Tumor Killing Assays Service Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Immune Mediated Tumor Killing Assays Service Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Immune Mediated Tumor Killing Assays Service Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Immune Mediated Tumor Killing Assays Service Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Immune Mediated Tumor Killing Assays Service Market Size Breakdown by Type (2021-2026)
3 Immune Mediated Tumor Killing Assays Service Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Cancer Research
  3. 3.1.2 Infectious Disease Research
  4. 3.1.3 Immunotherapy Development
  5. 3.2 Global Immune Mediated Tumor Killing Assays Service Market Size by Application
  6. 3.2.1 Global Immune Mediated Tumor Killing Assays Service Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Immune Mediated Tumor Killing Assays Service Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Immune Mediated Tumor Killing Assays Service Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Immune Mediated Tumor Killing Assays Service Market Size by Regions
  10. 3.3.1 North America Immune Mediated Tumor Killing Assays Service Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Immune Mediated Tumor Killing Assays Service Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Immune Mediated Tumor Killing Assays Service Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Immune Mediated Tumor Killing Assays Service Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Immune Mediated Tumor Killing Assays Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Immune Mediated Tumor Killing Assays Service Industry Trends
  2. 4.2 Immune Mediated Tumor Killing Assays Service Industry Drivers
  3. 4.3 Immune Mediated Tumor Killing Assays Service Industry Opportunities and Challenges
  4. 4.4 Immune Mediated Tumor Killing Assays Service Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Immune Mediated Tumor Killing Assays Service Revenue (2021-2026)
  2. 5.2 Global Immune Mediated Tumor Killing Assays Service Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Immune Mediated Tumor Killing Assays Service Key Company Headquarters & Area Served
  4. 5.4 Global Immune Mediated Tumor Killing Assays Service Company, Product Type & Application
  5. 5.5 Global Immune Mediated Tumor Killing Assays Service Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Immune Mediated Tumor Killing Assays Service Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Immune Mediated Tumor Killing Assays Service Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Immune Mediated Tumor Killing Assays Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Agilent
  2. 6.1.1 Agilent Company Information
  3. 6.1.2 Agilent Business Overview
  4. 6.1.3 Agilent Immune Mediated Tumor Killing Assays Service Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Agilent Immune Mediated Tumor Killing Assays Service Product Portfolio
  6. 6.1.5 Agilent Recent Developments
  7. 6.2 Laboratories
  8. 6.2.1 Laboratories Company Information
  9. 6.2.2 Laboratories Business Overview
  10. 6.2.3 Laboratories Immune Mediated Tumor Killing Assays Service Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Laboratories Immune Mediated Tumor Killing Assays Service Product Portfolio
  12. 6.2.5 Laboratories Recent Developments
  13. 6.3 Explicyte
  14. 6.3.1 Explicyte Company Information
  15. 6.3.2 Explicyte Business Overview
  16. 6.3.3 Explicyte Immune Mediated Tumor Killing Assays Service Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Explicyte Immune Mediated Tumor Killing Assays Service Product Portfolio
  18. 6.3.5 Explicyte Recent Developments
  19. 6.4 Reaction Biology
  20. 6.4.1 Reaction Biology Company Information
  21. 6.4.2 Reaction Biology Business Overview
  22. 6.4.3 Reaction Biology Immune Mediated Tumor Killing Assays Service Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Reaction Biology Immune Mediated Tumor Killing Assays Service Product Portfolio
  24. 6.4.5 Reaction Biology Recent Developments
  25. 6.5 Axion BioSystems
  26. 6.5.1 Axion BioSystems Company Information
  27. 6.5.2 Axion BioSystems Business Overview
  28. 6.5.3 Axion BioSystems Immune Mediated Tumor Killing Assays Service Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Axion BioSystems Immune Mediated Tumor Killing Assays Service Product Portfolio
  30. 6.5.5 Axion BioSystems Recent Developments
  31. 6.6 Sartorius
  32. 6.6.1 Sartorius Company Information
  33. 6.6.2 Sartorius Business Overview
  34. 6.6.3 Sartorius Immune Mediated Tumor Killing Assays Service Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Sartorius Immune Mediated Tumor Killing Assays Service Product Portfolio
  36. 6.6.5 Sartorius Recent Developments
  37. 6.7 ICE Bioscience
  38. 6.7.1 ICE Bioscience Company Information
  39. 6.7.2 ICE Bioscience Business Overview
  40. 6.7.3 ICE Bioscience Immune Mediated Tumor Killing Assays Service Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 ICE Bioscience Immune Mediated Tumor Killing Assays Service Product Portfolio
  42. 6.7.5 ICE Bioscience Recent Developments
  43. 6.8 Shanghai Saily Biotechnology
  44. 6.8.1 Shanghai Saily Biotechnology Company Information
  45. 6.8.2 Shanghai Saily Biotechnology Business Overview
  46. 6.8.3 Shanghai Saily Biotechnology Immune Mediated Tumor Killing Assays Service Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Shanghai Saily Biotechnology Immune Mediated Tumor Killing Assays Service Product Portfolio
  48. 6.8.5 Shanghai Saily Biotechnology Recent Developments
  49. 6.9 ProBio
  50. 6.9.1 ProBio Company Information
  51. 6.9.2 ProBio Business Overview
  52. 6.9.3 ProBio Immune Mediated Tumor Killing Assays Service Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 ProBio Immune Mediated Tumor Killing Assays Service Product Portfolio
  54. 6.9.5 ProBio Recent Developments
  55. 6.10 Charles River
  56. 6.10.1 Charles River Company Information
  57. 6.10.2 Charles River Business Overview
  58. 6.10.3 Charles River Immune Mediated Tumor Killing Assays Service Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Charles River Immune Mediated Tumor Killing Assays Service Product Portfolio
  60. 6.10.5 Charles River Recent Developments
  61. 6.11 Imodels
  62. 6.11.1 Imodels Company Information
  63. 6.11.2 Imodels Business Overview
  64. 6.11.3 Imodels Immune Mediated Tumor Killing Assays Service Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Imodels Immune Mediated Tumor Killing Assays Service Product Portfolio
  66. 6.11.5 Imodels Recent Developments
  67. 6.12 Xeno Diagnostics
  68. 6.12.1 Xeno Diagnostics Company Information
  69. 6.12.2 Xeno Diagnostics Business Overview
  70. 6.12.3 Xeno Diagnostics Immune Mediated Tumor Killing Assays Service Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Xeno Diagnostics Immune Mediated Tumor Killing Assays Service Product Portfolio
  72. 6.12.5 Xeno Diagnostics Recent Developments
  73. 6.13 Cyagen
  74. 6.13.1 Cyagen Company Information
  75. 6.13.2 Cyagen Business Overview
  76. 6.13.3 Cyagen Immune Mediated Tumor Killing Assays Service Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Cyagen Immune Mediated Tumor Killing Assays Service Product Portfolio
  78. 6.13.5 Cyagen Recent Developments
  79. 6.14 MarinBio
  80. 6.14.1 MarinBio Company Information
  81. 6.14.2 MarinBio Business Overview
  82. 6.14.3 MarinBio Immune Mediated Tumor Killing Assays Service Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 MarinBio Immune Mediated Tumor Killing Assays Service Product Portfolio
  84. 6.14.5 MarinBio Recent Developments
  85. 6.15 Pharmalegacy
  86. 6.15.1 Pharmalegacy Company Information
  87. 6.15.2 Pharmalegacy Business Overview
  88. 6.15.3 Pharmalegacy Immune Mediated Tumor Killing Assays Service Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Pharmalegacy Immune Mediated Tumor Killing Assays Service Product Portfolio
  90. 6.15.5 Pharmalegacy Recent Developments
  91. 6.16 Celentyx
  92. 6.16.1 Celentyx Company Information
  93. 6.16.2 Celentyx Business Overview
  94. 6.16.3 Celentyx Immune Mediated Tumor Killing Assays Service Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Celentyx Immune Mediated Tumor Killing Assays Service Product Portfolio
  96. 6.16.5 Celentyx Recent Developments
  97. 6.17 Crown Bioscience
  98. 6.17.1 Crown Bioscience Company Information
  99. 6.17.2 Crown Bioscience Business Overview
  100. 6.17.3 Crown Bioscience Immune Mediated Tumor Killing Assays Service Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Crown Bioscience Immune Mediated Tumor Killing Assays Service Product Portfolio
  102. 6.17.5 Crown Bioscience Recent Developments
  103. 6.18 Cellomatics Biosciences
  104. 6.18.1 Cellomatics Biosciences Company Information
  105. 6.18.2 Cellomatics Biosciences Business Overview
  106. 6.18.3 Cellomatics Biosciences Immune Mediated Tumor Killing Assays Service Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Cellomatics Biosciences Immune Mediated Tumor Killing Assays Service Product Portfolio
  108. 6.18.5 Cellomatics Biosciences Recent Developments
7 North America
  1. 7.1 North America Immune Mediated Tumor Killing Assays Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Immune Mediated Tumor Killing Assays Service Market Size by Country (2021-2026)
  3. 7.3 North America Immune Mediated Tumor Killing Assays Service Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Immune Mediated Tumor Killing Assays Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Immune Mediated Tumor Killing Assays Service Market Size by Country (2021-2026)
  3. 8.3 Europe Immune Mediated Tumor Killing Assays Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Immune Mediated Tumor Killing Assays Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Immune Mediated Tumor Killing Assays Service Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Immune Mediated Tumor Killing Assays Service Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Immune Mediated Tumor Killing Assays Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Immune Mediated Tumor Killing Assays Service Market Size by Country (2021-2026)
  3. 10.3 South America Immune Mediated Tumor Killing Assays Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst